Apogee Therapeutics Inc (APGE) PT Lowered to $81 at Truist Securities

May 27, 2026 12:39 PM

Truist Securities analyst Danielle Brill lowered the price target on Apogee Therapeutics Inc (NASDAQ: APGE) to $81.00 (from $83.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found